Robert Young Kim - Mar 6, 2025 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role: Chief Medical Officer
Signature: /s/ Scott Bizily as Attorney-in-Fact for Robert Young Kim
Stock symbol: FDMT
Transactions as of: Mar 6, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/10/2025, 07:58 PM
Previous filing: Feb 7, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FDMT	Stock Option (Right to Buy)	Award	$0	+92.3K		$0.00	92.3K	Mar 6, 2025	Common Stock	92.3K	$4.14	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Content

The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.